HPV (+) tonsil squamous cell carcinoma (TSCC)-related death remain unresolved.
CD4 (+), CD8 (+), and CD68 (+) cells were used to evaluate immunological condition.
Peritumoral distribution and the numbers of these cells were related to prognosis.
These differences could be determining factors for CCRT outcomes in HPV (+) TSCC patients.